How NFD improves impurity detection and peak integration in CE SDS workflows

Apr 28, 2026 | Biopharma, BioPhase 8800 system, Blogs | 0 comments

CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.

Native fluorescence detection (NFD) strengthens CE‑SDS performance by improving both detection sensitivity and interpretability.

 

High sensitivity without labeling

NFD leverages intrinsic tryptophan fluorescence to detect proteins label‑free, avoiding the variability and workflow burden of dye‑labeling steps.

Technical note data show:

  • Heavy‑chain S/N improved from 78 (UV) to 185 (NFD)
  • Impurity detection down to 0.01% via enhanced sensitivity and flatter baselines
  • Dose‑dependent detection of low‑spiked lysozyme impurities with strong linearity (R² = 0.9999)

For scientists managing stability programs or performing forced degradation studies, this sensitivity can reveal early‑stage degradation signatures that UV cannot reliably resolve.

 

Clearer, more stable baselines for better integration

Typical UV electropherograms show baseline drifting due to buffer absorbance and gel heterogeneity.

The NFD baseline, however, is consistently flat, improving:

  • Peak boundary definition
  • Automated integration accuracy
  • Review and approval cycles

These benefits reduce manual reprocessing and strengthen data defensibility across development stages.

 

Multi-capillary throughput for faster studies

The BioPhase 8800 system processes 8 samples in parallel, expanding CE‑SDS throughput without requiring additional instruments or longer sequences.

High‑throughput CE‑SDS paired with NFD’s sensitivity provides a strong foundation for data‑driven therapeutic development.

 

A balanced upgrade path from UV and LIF

NFD complements existing detection modes:

  • UV remains essential for bridging legacy data
  • LIF remains the most sensitive tool for dye‑labeled assays
  • NFD occupies the ideal middle ground with label‑free sensitivity and stable baselines

This offers scientists flexibility while building long‑term method robustness.

 

Explore the CE‑SDS NFD data

For deeper review, check out the resources in our NFD solutions hub >

 

Celebrating customer experience: Insights from SCIEX leaders

Customer Experience Day (CX Day) is a special occasion for SCIEX, celebrated every first Tuesday in October. It’s a day dedicated to recognizing the incredible value of our customers and the relentless dedication of our associates who strive to make every interaction meaningful. At SCIEX, our commitment to customer experience is woven into the fabric of everything we do. From providing cutting-edge solutions to offering unwavering support, we aim to build lasting relationships and exceed expectations. Join us as we delve into the insights from our leaders on what customer experience means to SCIEX and how it shapes our journey.

Why traditional MS/MS falls short for ADCs and how electron-activated dissociation (EAD) changes the equation

Antibody-drug conjugates (ADCs) are among the most promising—and analytically demanding—modalities in biopharma today. By combining large, heterogeneous antibodies with chemically labile payloads and linkers, ADCs introduce a level of structural complexity that challenges conventional analytical workflows. It also poses the challenge that the very features you need to measure are often the easiest to lose during analysis.

Six benefits of remote support every laboratory should know

Imagine having a tech expert at your fingertips to solve computer issues or a fitness trainer guiding you through workouts from the comfort of your home. In today’s fast-paced world, the ability to provide and receive service and support remotely is no longer a luxury but a necessity. Whether it’s troubleshooting a software issue, repairing a device, offering customer assistance, or enjoying the convenience of telehealth as a private individual, remote capabilities have revolutionized how businesses operate and how individuals get help

Posted by

Roxana has over 15 years of experience in sales and marketing roles in the MS community. As Senior Global Marketing Manager for protein therapeutics at SCIEX, she specializes in communicating innovations in MS and CE-based workflows to the biopharma community.

Tags


0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network